MSP Recovery, Inc. (MSPR) Form 424B3 — Aug 31, 2026
MSP Recovery filed Prospectus Supplement No. 70 to its February 7, 2024 prospectus, registering 285,715 Class A shares for resale by Yorkville under the parties' $250 million Standby Equity Purchase Agreement, and attaching the company's Form 8-K dated August 31, 2026. The embedded 8-K discloses two one-time $0.03 million advances from lender Hazel Partners Holdings under the Operational Collection Floor, funded August 18 and August 28, 2026, plus two $0.03 million recovery-proceeds advances from VRM MSP Recovery Partners under the Third and Fourth Addenda, funded August 14 and August 28, 2026, all earmarked primarily for operating and operational expenses.
Key figures
- Shares Offered
- 285715
- Exchange cap
- 158,295 shares (19.99% of voting common stock); lifted effective January 8, 2025
- Vrm advance 1
- $0.03 million (funded August 14, 2026)
- Vrm advance 2
- $0.03 million (funded August 28, 2026)
- Hazel advance 1
- $0.03 million (funded August 18, 2026)
- Hazel advance 2
- $0.03 million (funded August 28, 2026)
- Note interest rate
- 5.0% annual, increasing to 18.0% upon event of default
- Reverse split ratio
- 1-for-7 (effective September 1, 2025)
- Ownership limitation
- 9.99%
- Current trading venue
- OTC Expert Market — no publicly available quotations
- Nasdaq delisting date
- December 22, 2025
- Note maturity original
- November 30, 2026 (may be extended at Yorkville discretion)
- Yorkville sepa commitment
- $250 million
- Note maturity supplemental
- March 31, 2027 (may be extended at Yorkville discretion)
- Yorkville floor price current
- $0.50 per share
- Yorkville floor price original
- $224.00 per share
- Second supplemental agreement capacity
- up to $3.0 million at 10% original issue discount
- Operational collection floor previously drawn
- approximately $6.0 million with no remaining capacity as of Q3-2025 10-Q
- Yorkville convertible notes aggregate principal
- $15.75 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.